11 The Knee: Guided Injection Techniques



10.1055/b-0038-161016

11 The Knee: Guided Injection Techniques



Abstract


This chapter outlines commonly used injection techniques around the knee joint. The aim is to detail the position and alignment of the probe and needle to allow accurate placement into the target tissue. In addition, a brief clinical presentation is given for each condition as well as some of the anatomical considerations which should be noted. The drugs, dosages, and volumes given are those used in the author’s clinic.




11.1 Knee Joint Aspiration/Injection



11.1.1 Cause




  • Osteoarthritis, rheumatoid arthritis, or trauma.



11.1.2 Presentation


An effusion may be visible or detected on clinical examination. The patient may be able to describe an initiating traumatic event or change in activity which precipitated an exacerbation of pain and swelling. However, in the patient with osteoarthritis the patient may be unable to describe any such mechanism.



11.1.3 Equipment


See Table  11‑1.























Table 11.1 Equipment needed for knee joint aspiration/injection

Syringe


Needle


Corticosteroid


Local anesthetic


Transducer


10 mL


21 gauge – 2 inch



40-mg Depo-Medrone


5-mL 1% lidocaine


Large linear footprint



11.1.4 Anatomical Considerations


The safest and easiest technique is to use a lateral to medial approach immediately proximal to the superior edge of the patella. The clinician need not worry about any major blood vessels or nerves if this technique is used and excellent needle visualization is obtained for both aspiration if needed and injection.



11.1.5 Procedure




  • Supine with the knee flexed approximately 20 degrees.



  • Transducer placed in the transverse plane over the suprapatellar recess.



  • Needle introduced lateral to medial in long axis to the transducer.



  • Aim for the suprapatellar recess between the quadriceps tendon or quadriceps fat pad (superficial) and prefemoral fat (deep).


Note: Medial/lateral patellar gliding can improve identification of the suprapatellar recess.



11.1.6 The Aspiration/Injection


See Fig.  11‑1 and Fig.  11‑2.

Fig. 11.1 Knee joint aspiration/injection. The probe is placed in the transverse plane over the suprapatellar recess. The needle is introduced from the lateral to medial in long axis to the probe. Aim for the suprapatellar recess between the quadriceps tendon and quadriceps fat pad (superficial) and prefemoral fat (deep).
Fig. 11.2 Transverse image of the suprapatellar region of the knee. The quadriceps tendon may be seen at the top of the image (shaded oval). The suprapatellar pouch is effused (white stars). A needle may be seen to enter the suprapatellar pouch from the lateral side (note the reverberation artefact). Blue curved arrow, prefemoral fat; shaded oval, quadriceps tendon; VMO, vastus medialis obliquus; white stars, suprapatellar effusion; yellow curved arrow, suprapatellar fat.


11.1.7 Notes


In the case of trauma the possibility of a fracture should be excluded before an injection is considered. This is particularly the case in the elderly or osteoporotic patient who may sustain a fracture in return for a relatively innocuous injury. In the case of the younger patient consider a meniscal injury, ligamentous damage, or osteochondral lesion prior to injection.


In addition as in any corticosteroid injection infection or reactive arthritis should be considered when presented with an effused knee for which the patient can describe no significant initiating trauma.


If no effusion is present in the suprapateller region it may be easier to give the injection into the medial margin of the patellofemoral joint. In this case, the probe is placed in the transverse plane over the patella and medial patella femoral joint. The needle is introduced in line with the probe at a 45 degree angle deep to the patella.


In the case of an osteoarthritic knee with no clear effusion consider injection of a hyaluronan rather than a corticosteroid.



11.2 Semimembranosus Bursa/Baker’s Cyst Aspiration/Injection



11.2.1 Cause


Spontaneous and insidious onset. The Baker’s cyst is often related to an underlying osteoarthritis of the knee joint. In the case of a semimembranosus bursa onset may follow a history of repetitive sporting activity such as repeated deep squatting during powerlifting.



11.2.2 Presentation


Swelling in the popliteal fossa may be quite large. More subtle swellings may only be seen on ultrasound.



11.2.3 Equipment


See Table  11‑2.




















Table 11.2 Equipment needed for semimembranosus bursa/Baker’s cyst aspiration/injection

Syringe


Needle


Corticosteroid


Local anesthetic


10 or 20 mL


21 gauge


N/A


N/A



11.2.4 Anatomical Considerations


A Baker’s cyst is a synovial fluid–filled herniation through the posterior wall of the knee joint capsule. The cyst can usually be seen to originate deeply from the posterior aspect of the joint extending between the tendon of the medial gastrocnemius medially and the tendon of semimembranosus laterally in transverse imaging. Smaller swellings may represent a distension of the semimembranosus bursa in which case there may be no clear extension more deeply.



11.2.5 Procedure




  • The patient is positioned in prone with the knee supported on a pillow.



  • The transducer is placed in the anatomical sagittal plane.



  • The needle is introduced in a line progressing from inferior to superior in the long axis of the transducer.



  • Fluid is aspirated from the bursa.



  • If injection is also required, the needle may be left in place and a fresh syringe connected with the injectable drug.



  • Injection is given as a bolus.



11.2.6 The Aspiration/Injection


See Fig.  11‑3 and Fig.  11‑4.

Fig. 11.3 Aspiration/injection of a semimembranosus bursa/Baker’s cyst. The probe is placed in the anatomical sagittal plane. The needle is introduced in a line progressing from inferior to superior in the long axis of the probe. Fluid is aspirated from the bursa. If injection is also required, the needle may be left in place and a fresh syringe connected with the injectable drug.
Fig. 11.4 Longitudinal image of the medial aspect of the popliteal fossa. The Baker’s cyst appears as a large well-defined anechoic swelling laying superficially to the medial head of gastrocnemius (MHG). The needle direction is indicated by the yellow arrow and is in an inferior to superior line. Note the posterior enhancement (arrowheads) which indicate the swelling is of relatively low density.


11.2.7 Notes


Identify the popliteal artery, veins, and tibial nerve which should be seen medial to the swelling. The cyst/bursa may be lobulated and require that the different parts are targeted. In the case of the semimembranosus bursa corticosteroid injection may follow aspiration.


It should be noted that a Baker’s cyst is often related to an underlying osteoarthritis of the knee joint. In such cases treatment should be directed at the osteoarthritis as the predisposing factor.


When imaging the popliteal fossa, an accessory fabella (Latin for little bean) may be noted lying within the medial or lateral gastrocnemius tendon. This small sesamoid bone is a normal variant present in 10 to 30% of patients. Rarely there may be two to three of these bones (fabella bi or tripartite). The fabella rarely causes problems unless the patient’s occupation or sport involves repeated end-range flexion and heavy loading of the knee such as required in powerlifting or weightlifting. In this case guided injection around the fabella may be of both diagnostic and therapeutic benefit.


Although relatively rare, a popliteal artery aneurysm should always be excluded with the use of Doppler imaging. Popliteal artery aneurysms are the most common true peripheral aneurysm occurring more frequently than femoral artery aneurysm but less frequently than abdominal aortic aneurysm.



11.3 Distal Iliotibial Band/Bursa Injection



11.3.1 Cause




  • Commonly overuse.



  • Often related to long distance running or fell running.



11.3.2 Presentation


The patient describes pain over the lateral aspect of the knee which may be diffuse in nature but on palpation centered over the lateral femoral condyle. If the bursa is inflamed, there may be a palpable swelling.



11.3.3 Equipment


See Table  11‑3.




















Table 11.3 Equipment needed for distal iliotibial band/bursa injection

Syringe


Needle


Corticosteroid


Local anesthetic


5 mL


23 gauge – 1.25 inch


20-mg Depo-Medrone


2-mL 1% lidocaine



11.3.4 Anatomical Considerations


The bursa lies deep to the iliotibial band over the lateral femoral condyle of the femur. In its normal state it is not visible on ultrasound.



11.3.5 Procedure




  • The patient is positioned in side lying with the symptomatic side up and knee flexed to 20 degrees and supported on a pillow.



  • The transducer is placed in the anatomical coronal plane so that it lies longitudinally over the iliotibial band at the level of the lateral femoral condyle.



  • The needle is introduced from a superior to inferior line in the long axis of the transducer.



  • The needle tip should be positioned between the iliotibial band and the lateral femoral condyle.



11.3.6 The Injection


See Fig.  11‑5 andFig.  11‑6.

Fig. 11.5 Injection of the distal iliotibial band/bursa. The probe is placed in the anatomical coronal plane over the iliotibial band at the level of the lateral femoral condyle. The needle is introduced from a superior to inferior line in the long axis of the transducer. The needle tip should be positioned between the iliotibial band and the lateral femoral condyle.
Fig. 11.6 Longitudinal image of the distal iliotibial band (short yellow arrows). The lateral femoral condyle (LFC) may be seen deep to the iliotibial band. The direction of the needle is indicated by the long yellow arrow. VL, vastus lateralis.


11.3.7 Notes


Inflammation and distension of the bursa is unusual. More commonly the bursa itself cannot be seen on imaging, but the iliotibial band appears thickened suggesting a more chronic condition. If this is the case, a higher-volume injection may be given with up to 10 mL to help stretch and free any adhesions.


As always the patient should be assessed in regard to any muscle imbalance or tightness of the iliotibial band itself. In addition, gait analysis should be considered if foot position is considered an issue.



11.4 Pes Anserine Bursa/Tendon Injection



11.4.1 Cause




  • Most commonly overuse.



  • Often related to long-distance running.



11.4.2 Presentation


The patient describes pain over the superior medial aspect of the tibia at the insertion of the tendons of sartorius, semitendinosus, and gracilis (pes anserine tendons). There may be some pain on resisted knee flexion. More commonly the only clinical finding is pain to direct palpation. If the bursa is inflamed, there may be a visible swelling.



11.4.3 Equipment


See Table  11‑4.




















Table 11.4 Equipment needed for pes anserine bursa/tendon injection

Syringe


Needle


Corticosteroid


Local anesthetic


5 mL


25 gauge – 1 inch



20-mg Depo-Medrone


2-mL 1% lidocaine


Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

May 21, 2020 | Posted by in ORTHOPEDIC | Comments Off on 11 The Knee: Guided Injection Techniques

Full access? Get Clinical Tree

Get Clinical Tree app for offline access